Quick exitLeave this site quickly

Medicines A–Z

Every medicine used in gender-affirming hormone therapy in Australia, plus the medicines commonly used alongside it — with an in-depth page for each: how it is used, what it costs, what is monitored, and where it sits for supply.

← Back to supply & shortages

Stock seen by patients

What people have reported seeing on pharmacy shelves, newest first and grouped by medicine. All patient sightings are unverified: they are reports from the public, not confirmed stock levels. Always ring the pharmacy before travelling. To have a report removed, use the feedback page (preferred) or email [email protected].

Share a sighting →

← Back to all medicines

Sequential estradiol and norethisterone tablets (Trisequens)

A tablet pack that cycles through three combinations of two hormones — estradiol (an oestrogen) alone, then estradiol with norethisterone acetate (a progestogen) added, then estradiol alone again — designed to produce a monthly bleed. It is registered in Australia for menopausal hormone therapy in someone with a uterus, not for gender-affirming care, and Australian guidance on feminising hormone therapy does not recommend routinely adding a progestogen. This entry is background for someone who has already been prescribed it — it is not an argument against your prescriber's choice.

Estradiol + norethisterone acetate · sold as Trisequens

Available in Australia?AvailableTGA records checked 21 Nov 2026.See supply detail

What it is

Trisequens is a single product that changes composition through the pack. For twelve days it's estradiol alone; for ten days norethisterone acetate, a progestogen (a synthetic hormone related to progesterone), is added; then it drops back to estradiol alone for the last six days — a pattern built to mimic a natural cycle and trigger a withdrawal bleed toward the end of each pack[2].

It's registered for menopausal hormone therapy in someone who still has a uterus (womb), where the progestogen phase protects the uterine lining (endometrium) from building up unopposed under oestrogen. That protective role isn't relevant for most people on feminising hormone therapy, who don't have a uterus[2].

The product information says combined hormone therapy like this should not be used after a hysterectomy (an operation to remove the womb): the progestogen is not needed, and it may increase the risk of breast cancer[6].

The Australian position statement on transgender and gender diverse hormone management doesn't support routinely adding a progestogen for feminising goals: "despite anecdotal reports that progestins increase breast growth, no data support their use," and progestins "can also increase risk of thrombosis, bloating, nausea and weight gain and are not recommended"[1]. Australia's 2026 standards of care add that progestogens are no longer standard practice in feminising hormone therapy and that, if one is used, micronised progesterone is generally preferred over synthetic progestins such as the one in this product[5].

Unlike the continuous combined products on this page (Kliogest, Femoston-Conti, Angeliq), Trisequens is specifically built to produce a scheduled monthly bleed. If you've been prescribed it, that's worth asking about directly — a bleed is the expected, designed-in effect of the progestogen phase here, not a side effect to worry about, but it's also a clear sign the product is doing something a plain oestrogen tablet wouldn't do.

Gender-Affirming Medicines South Australia

Clear, referenced information on gender-affirming medicines in South Australia — hormones, blockers and everything that happens at the pharmacy — for our community, and the people who care for, prescribe and dispense them.

What do you need today?

Guides

  • ReferencedSources cited on every guide
  • Pharmacist-writtenBy a registered pharmacist in Adelaide
  • Kept currentSupply checked daily from TGA records; PBS prices monthly
  • PrivateNo cookies, no tracking, Quick exit

Looking for a prescriber?

The Trans Health SA directory lists GPs, clinics and services across South Australia. Your pharmacist can also tell you which local prescribers regularly prescribe gender-affirming hormones.

Supply & shortages

Which hormone therapy medicines are hard to get in Australia right now, and what it means for you.

No supply problems reported

    Pharmacy stock reports

    What registered pharmacists say is on their shelves right now, checked against the AHPRA register before publishing. The official data above tells you about Australia; this tells you about particular pharmacies.

    See all pharmacy stock reports   Pharmacists: post a report →

    Seen it in stock, or missed out?

    Reports from other patients about what their local pharmacy had on the shelf. This sits alongside the official data above until a verified pharmacy stock feed is in place.

    Anonymous. No account, no personal details, and please don't put a person's name in the note.

    If your medicine is affected

    Start with your pharmacist — they can check other suppliers, order it in, and for the oestrogen patches can often supply an approved alternative without a new prescription. Filling your script a few days early, rather than on the last day, gives everyone room to move.

    ← Back to supply & shortages

    Pharmacy stock reports

    Stock reports posted by registered pharmacists, newest first. Each pharmacist's registration number is checked against the AHPRA register before their first report is published; after that their reports appear straight away.

    Post a report

    For pharmacists, and pharmacy staff posting on a pharmacist's behalf. Your name, registration number and work email (if you give one) are stored, and only the author can see them. Your registration number is never shown. The pharmacy name, suburb, medicine, stock position and note are public. To correct or remove a report, use the feedback page (preferred) or email [email protected].

    Not for promoting your pharmacy: report stock facts only. By posting you confirm you are a registered pharmacist, or are posting with one's permission, and that the report is accurate at the time of posting. Reports expire after 14 days.

    Send feedback

    Spotted something wrong, out of date or missing? Tell us here. Every message is read, and corrections are made as quickly as possible. The form is the preferred way to reach us; if you cannot use it, email [email protected].

    Please do not include personal health details. Messages are stored privately and never shared, and no tracking cookies are used.